Venrock Associates IV L P is 10% Owner at Bellerophon Therapeutics, Inc. (BLPH). They have made 1 open-market trade across 1 company since 2019, most recently 2019-01-23.
CIK 0001277997
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLPH | 7,529,020 | $772K |
Shares reported on the most recent Form 4, priced at the 2019-03-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLPH | BUY | 2019-01-23 | 2019-03-14 | $0.70 | $100K | -7.1% | -7.9% | -9.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.